학술논문
Maternal immunoglobulin treatment can reduce severity of fetal acetylcholine receptor antibody-associated disorders (FARAD).
Document Type
Article
Source
Neurological Research & Practice; 10/26/2023, Vol. 5 Issue 1, p1-4, 4p
Subject
Language
Abstract
Copyright of Neurological Research & Practice is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)